A Study in Subjects With Retinitis Pigmentosa
Trial details
- Registry ID
- NCT05392179
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study in Subjects With Retinitis PigmentosaNCT05392179 | ALDX | Phase 2 | Completed | 2023-06-23Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |